KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Convertible Debt Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Leases Finished Goods Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Long-Term Deferred Tax Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

ClearPoint Neuro (CLPT) Short-term Investments (2022 - 2023)

Historic Short-term Investments for ClearPoint Neuro (CLPT) over the last 2 years, with Q1 2023 value amounting to $9.9 million.

ClearPoint Neuro's Short-term Investments changed N/A to $9.9 million in Q1 2023 from the same period last year, while for Mar 2023 it was $9.9 million, marking a year-over-year change of. This contributed to the annual value of $9.9 million for FY2022, which is N/A changed from last year.
As of Q1 2023, ClearPoint Neuro's Short-term Investments stood at $9.9 million.
ClearPoint Neuro's 5-year Short-term Investments high stood at $21.7 million for Q3 2022, and its period low was $9.9 million during Q4 2022.